BIOPX vs. FPHAX
Compare and contrast key facts about Baron Opportunity Fund (BIOPX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
BIOPX is managed by Baron Capital Group, Inc.. It was launched on Feb 29, 2000. FPHAX is managed by Fidelity. It was launched on Jun 17, 2001.
Performance
BIOPX vs. FPHAX - Performance Comparison
Loading graphics...
BIOPX vs. FPHAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIOPX Baron Opportunity Fund | -8.95% | 19.44% | 39.87% | 49.55% | -42.96% | 11.90% | 88.78% | 40.34% | 8.06% | 40.58% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.39% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
Returns By Period
In the year-to-date period, BIOPX achieves a -8.95% return, which is significantly lower than FPHAX's 0.39% return. Over the past 10 years, BIOPX has outperformed FPHAX with an annualized return of 19.59%, while FPHAX has yielded a comparatively lower 11.27% annualized return.
BIOPX
- 1D
- 3.58%
- 1M
- -4.64%
- YTD
- -8.95%
- 6M
- -5.34%
- 1Y
- 22.42%
- 3Y*
- 24.52%
- 5Y*
- 7.16%
- 10Y*
- 19.59%
FPHAX
- 1D
- 3.02%
- 1M
- -5.31%
- YTD
- 0.39%
- 6M
- 13.18%
- 1Y
- 34.09%
- 3Y*
- 17.36%
- 5Y*
- 12.54%
- 10Y*
- 11.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIOPX vs. FPHAX - Expense Ratio Comparison
BIOPX has a 1.31% expense ratio, which is higher than FPHAX's 0.75% expense ratio.
Return for Risk
BIOPX vs. FPHAX — Risk / Return Rank
BIOPX
FPHAX
BIOPX vs. FPHAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Baron Opportunity Fund (BIOPX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIOPX | FPHAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.93 | 1.33 | -0.40 |
Sortino ratioReturn per unit of downside risk | 1.50 | 1.84 | -0.34 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.24 | -0.03 |
Calmar ratioReturn relative to maximum drawdown | 1.64 | 2.50 | -0.85 |
Martin ratioReturn relative to average drawdown | 5.38 | 7.03 | -1.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BIOPX | FPHAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.93 | 1.33 | -0.40 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | 0.71 | -0.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.79 | 0.64 | +0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.53 | -0.15 |
Correlation
The correlation between BIOPX and FPHAX is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
BIOPX vs. FPHAX - Dividend Comparison
BIOPX's dividend yield for the trailing twelve months is around 4.65%, less than FPHAX's 5.66% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIOPX Baron Opportunity Fund | 4.65% | 4.24% | 4.95% | 0.00% | 0.00% | 8.71% | 6.96% | 7.33% | 5.29% | 15.58% | 13.52% | 10.92% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.66% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
Drawdowns
BIOPX vs. FPHAX - Drawdown Comparison
The maximum BIOPX drawdown since its inception was -67.91%, which is greater than FPHAX's maximum drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for BIOPX and FPHAX.
Loading graphics...
Drawdown Indicators
| BIOPX | FPHAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.91% | -38.26% | -29.65% |
Max Drawdown (1Y)Largest decline over 1 year | -14.16% | -11.00% | -3.16% |
Max Drawdown (5Y)Largest decline over 5 years | -51.45% | -28.82% | -22.63% |
Max Drawdown (10Y)Largest decline over 10 years | -51.45% | -28.82% | -22.63% |
Current DrawdownCurrent decline from peak | -11.09% | -7.10% | -3.99% |
Average DrawdownAverage peak-to-trough decline | -16.97% | -9.21% | -7.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.33% | 4.30% | +0.03% |
Volatility
BIOPX vs. FPHAX - Volatility Comparison
Baron Opportunity Fund (BIOPX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX) have volatilities of 6.73% and 6.89%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BIOPX | FPHAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.73% | 6.89% | -0.16% |
Volatility (6M)Calculated over the trailing 6-month period | 14.24% | 14.30% | -0.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.54% | 23.52% | +2.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.84% | 17.74% | +9.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.84% | 17.81% | +7.03% |